Avoid Excessive Use of Trelegy Ellipta and Avoid Use with Other Long-acting Beta2-agonists Do not exceed the recommended dose. Clinically significant cardiovascular effects and fatalities have ...

Using Trelegy Ellipta may cause a false-negative test result, meaning the test doesn’t show TB even if you actually have it. This effect may last for up to 6 weeks after your last dose of ...

The FDA has approved GlaxoSmithKline’s Trelegy Ellipta inhaler for asthma in adults ... coupled with a convenient once-daily dosing regimen. AstraZeneca is also aiming for an approval for ...

GlaxoSmithKline and partner Innoviva are seeking an expansion to the US label of their Trelegy Ellipta lung drug ... to take their medicine in a daily dose in a single inhaler, rather than ...